FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
1-Year Return
33.17%
This Quarter Return
+26.49%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$988M
AUM Growth
+$129M
(+15%)
Cap. Flow
+$596K
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
50.06%
Holding
77
New
6
Increased
26
Reduced
14
Closed
6
Top Buys
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$26.5M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$9.11M |
| 3 |
Transmedics
TMDX
|
$6.42M |
| 4 |
Direxion Daily S&P Biotech Bull 3X Shares
LABU
|
$6.01M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
$5.15M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$24.2M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$10.6M |
| 3 |
Krystal Biotech
KRYS
|
$7.18M |
| 4 |
Codexis
CDXS
|
$7.17M |
| 5 |
MODN
MODEL N, INC.
MODN
|
$4.98M |
Sector Composition
| 1 | Healthcare | 86.29% |
| 2 | Communication Services | 9.04% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
KORU Medical Systems
KRMD
$190M
| $14M | 1.42% |
6,273,773
+170,839
| +3% | +$381K |
|
|
NGM
27
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $12.5M | 1.26% |
955,505
-180,379
| -16% | -$2.36M |
|
28
Health Catalyst
HCAT
$232M
| $11.2M | 1.13% |
1,149,833
+14,668
| +1% | +$142K |
|
|
29
Mirum Pharmaceuticals
MIRM
$3.73B
| $11M | 1.11% |
522,864
+245,190
| +88% | +$5.15M |
|
30
BioMarin Pharmaceuticals
BMRN
$10.9B
| $10.5M | 1.06% |
123,322
+18,509
| +18% | +$1.57M |
|
31
Bioventus
BVS
$475M
| $9.79M | 0.99% |
1,398,922
+50,462
| +4% | +$353K |
|
32
CareDx
CDNA
$697M
| $9.36M | 0.95% |
549,797
-226,823
| -29% | -$3.86M |
|
|
PHLT
33
Performant Healthcare, Inc. Common Stock
PHLT
$605M
| $9.29M | 0.94% |
5,020,107
+330
| +0% | +$610 |
|
34
MaxCyte
MXCT
$145M
| $8.86M | 0.9% |
1,362,543
+43,054
| +3% | +$280K |
|
35
Pfizer
PFE
$140B
| $6.44M | 0.65% |
147,151
+795
| +0.5% | +$34.8K |
|
|
AKU
36
DELISTED
Akumin Inc. Common Stock (DE)
AKU
| $6.44M | 0.65% |
3,764,264
| – | – |
|
|
37
Transmedics
TMDX
$3.55B
| $6.42M | 0.65% |
+153,769
| New | +$6.42M |
|
|
38
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$723M
| $6.01M | 0.61% |
+42,891
| New | +$6.01M |
|
|
ABCM
39
DELISTED
Abcam plc American Depositary Shares
ABCM
| $5.75M | 0.58% |
383,557
+162,719
| +74% | +$2.44M |
|
40
OptimizeRx
OPRX
$345M
| $5.4M | 0.55% |
364,036
+3,275
| +0.9% | +$48.5K |
|
41
Genmab
GMAB
$16.8B
| $5.2M | 0.53% |
161,727
+842
| +0.5% | +$27.1K |
|
42
Castle Biosciences
CSTL
$670M
| $4.26M | 0.43% |
+163,224
| New | +$4.26M |
|
|
NARI
43
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.29M | 0.33% |
45,313
+284
| +0.6% | +$20.6K |
|
|
MIRO
44
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $2.26M | 0.23% |
516,007
| – | – |
|
45
Simulations Plus
SLP
$284M
| $1.75M | 0.18% |
36,061
-39,924
| -53% | -$1.94M |
|
46
Elevance Health
ELV
$69.4B
| $565K | 0.06% |
1,244
| – | – |
|
47
Cigna
CI
$81.2B
| $539K | 0.05% |
1,943
| – | – |
|
48
CVS Health
CVS
$93.5B
| $526K | 0.05% |
5,519
| – | – |
|
49
Humana
HUM
$37.5B
| $518K | 0.05% |
1,068
| – | – |
|
50
Bristol-Myers Squibb
BMY
$95B
| $516K | 0.05% |
7,256
| – | – |
|